Tonix Pharmaceuticals is currently enrolling participants in a Phase 3 trial for posttraumatic stress disorder (PTSD). For more information, please visit www.recoverystudy.com or www.clinicaltrials.gov (NCT03841773).

SEC Filings
: All SEC Filings

All SEC Filings

Filter Filings:
Date Form Description Docs XBRL Pages
11/15/19 8-K Current report filing
Related Documents
59
11/14/19 EFFECT Notice of Effectiveness 1
11/14/19 S-1/A General form of registration statement for all companies including face-amount certificate companies 51
11/14/19 8-K Current report filing 3
11/14/19 S-1/A General form of registration statement for all companies including face-amount certificate companies 190
11/08/19 FWP Filing under Securities Act Rules 163/433 of free writing prospectuses 26
11/08/19 8-K Current report filing
Related Documents
33
11/08/19 10-Q Quarterly report pursuant to Section 13 or 15(d) 115
11/04/19 8-K Current report filing
Related Documents
178
11/04/19 8-K Current report filing
Related Documents
6